Mydecine Innovations Group Announces Closing of $17,250,000 Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option
Stock Information for Mydecine Innovations Group Inc
Loading
Please wait while we load your information from QuoteMedia.